 | • レポートコード：MRC-IM30283 • 出版社/出版日：IMARC / 2022年11月 • レポート形態：英文、PDF、143ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥374,850 (USD2,499) | ▷ お問い合わせ |
| Enterprisewide | ￥674,850 (USD4,499) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| グローバル調査会社のIMARC社は、2021年に23億ドルであった世界の結核診断市場規模が、2022年から2027年の間にCAGR 5.32％で成長し、2027年までに31億ドルに達すると予測しています。本調査レポートでは、結核診断の世界市場について総合的に調査・分析し、序論、範囲・調査手法、エグゼクティブサマリー、イントロダクション、病期別（潜在性結核、活動性結核）分析、検査タイプ別（X線検査、実験室検査、核酸検査、サイトカイン検出検査、薬剤耐性検査）分析、エンドユーザー別（病院＆クリニック、診断研究室＆研究所、その他）分析、地域別（北米、アジア、欧州、中南米、中東・アフリカ）分析、SWOT分析（強み・弱み・機会・脅威）、バリューチェーン分析、ファイブフォース分析、価格指標、競争状況などの項目をまとめています。なお、本書に掲載されている企業情報には、Abbott Laboratories, Alere Inc., Becton Dickinson and Company, BioMérieux, Cepheid Inc., Epistem Ltd., Roche Holding AG, Hain Lifescience GmbH, Hologic Inc., QIAGEN GmbH, Siemens, Thermo Fisher Scientific Inc.などが含まれています。 ・序論 ・範囲・調査手法 ・エグゼクティブサマリー ・イントロダクション ・世界の結核診断市場規模：病期別 - 潜在性結核診断の市場規模 - 活動性結核診断の市場規模 ・世界の結核診断市場規模：検査タイプ別 - X線検査の市場規模 - 実験室検査の市場規模 - 核酸検査の市場規模 - サイトカイン検出検査の市場規模 - 薬剤耐性検査の市場規模 ・世界の結核診断市場規模：エンドユーザー別 - 病院＆クリニックにおける市場規模 - 診断研究室＆研究所における市場規模 - その他エンドユーザーにおける市場規模 ・世界の結核診断市場規模：地域別 - 北米の結核診断市場規模 - アジアの結核診断市場規模 - 欧州の結核診断市場規模 - 中南米の結核診断市場規模 - 中東・アフリカの結核診断市場規模 ・SWOT分析（強み・弱み・機会・脅威） ・バリューチェーン分析 ・ファイブフォース分析 ・価格指標 ・競争状況 |
The global tuberculosis diagnostics market size reached US$ 2.3 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 3.1 Billion by 2027, exhibiting a growth rate (CAGR) of 5.32% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Tuberculosis (TB) refers to an infectious bacterial disease that primarily affects the lungs (pulmonary), along with other parts of the body (extrapulmonary). The infection is diagnosed via a Mantoux tuberculin skin test (TST) or the TB blood test. Additional tests are required to confirm TB disease, depending on the infected organs. In the case of pulmonary TB, chest radiography is performed for detecting chest abnormalities, along with acid-fast staining and microscopic examination of the patient’s sputum. Extrapulmonary TB can be diagnosed using CT, MRI or ultrasound scans, endoscopy, laparoscopy, urine and blood tests, biopsies, and lumbar punctures.
Tuberculosis Diagnostics Market Trends:
The increasing prevalence of multi-drug resistant (MDR) tuberculosis across the globe is one of the key factors driving the growth of the market. MDR tuberculosis is caused by bacteria that are resistant to isoniazid and rifampicin, which are considered to be among the most potent antimicrobial drugs for TB. Furthermore, the availability of technologically advanced Point-of-Care (POC) diagnostic methods is also providing a boost to the market growth. Advanced diagnostic methods, such as Nucleic acid amplification tests (NAATs) and Interferon-Gamma Release Assay (IGRA), are more accurate, convenient, and provide prompt results in comparison to the traditionally used techniques. Additionally, significant improvements in the healthcare infrastructure, along with the growing awareness among the masses about various diagnostic procedures, are acting as another growth-inducing factor. Other factors, including the rising geriatric population and increasing healthcare expenditure and government initiatives and investments to promote research and development (R&D) activities, are projected to drive the market further.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global tuberculosis diagnostics market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on disease stage, test type, and end-user.
Breakup by Disease Stage:
Latent TB
Active TB
Breakup by Test Type:
Radiographic Test
Laboratory Test
Smear Microscopy
Culture-based Test
Nucleic Acid Testing
Cytokine Detection Test
Drug Resistance Test
Others
Breakup by End-User:
Hospitals and Clinics
Diagnostics and Research Laboratories
Others
Breakup by Region:
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined with some of the key players being Abbott Laboratories, Alere Inc., Becton Dickinson and Company, BioMérieux, Cepheid Inc., Epistem Ltd., Roche Holding AG, Hain Lifescience GmbH, Hologic Inc., QIAGEN GmbH, Siemens, Thermo Fisher Scientific Inc., etc.
Key Questions Answered in This Report:
How has the global tuberculosis diagnostics market performed so far and how will it perform in the coming years?
What are the key regional markets?
What has been the impact of COVID-19 on the global tuberculosis diagnostics market?
What is the breakup of the market based on the disease stage?
What is the breakup of the market based on the test type?
What is the breakup of the market based on the end-user?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global tuberculosis diagnostics market and who are the key players?
What is the degree of competition in the industry?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Tuberculosis Diagnostics Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Disease Stage
6.1 Latent TB
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Active TB
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Test Type
7.1 Radiographic Test
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Laboratory Test
7.2.1 Market Trends
7.2.2 Major Types
7.2.2.1 Smear Microscopy
7.2.2.2 Culture-based Test
7.2.3 Market Forecast
7.3 Nucleic Acid Testing
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Cytokine Detection Test
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Drug Resistance Test
7.5.1 Market Trends
7.5.2 Market Forecast
7.6 Others
7.6.1 Market Trends
7.6.2 Market Forecast
8 Market Breakup by End-User
8.1 Hospitals and Clinics
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Diagnostics and Research Laboratories
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Others
8.3.1 Market Trends
8.3.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Indicators
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Abbott Laboratories
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 Alere Inc.
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.3 Becton Dickinson and Company
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.3.4 SWOT Analysis
14.3.4 BioMérieux
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.4.4 SWOT Analysis
14.3.5 Cepheid Inc.
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 SWOT Analysis
14.3.6 Epistem Ltd.
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.7 Roche Holding AG
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 Financials
14.3.8 Hain Lifescience GmbH
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.9 Hologic Inc.
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.9.4 SWOT Analysis
14.3.10 QIAGEN GmbH
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
14.3.11 Siemens
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.11.3 Financials
14.3.11.4 SWOT Analysis
14.3.12 Thermo Fisher Scientific Inc.
14.3.12.1 Company Overview
14.3.12.2 Product Portfolio
14.3.12.3 Financials
14.3.12.4 SWOT Analysis
Figure 2: Global: Tuberculosis Diagnostics Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Tuberculosis Diagnostics Market: Breakup by Disease Stage (in %), 2021
Figure 4: Global: Tuberculosis Diagnostics Market: Breakup by Test Type (in %), 2021
Figure 5: Global: Tuberculosis Diagnostics Market: Breakup by End-User (in %), 2021
Figure 6: Global: Tuberculosis Diagnostics Market: Breakup by Region (in %), 2021
Figure 7: Global: Tuberculosis Diagnostics Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 8: Global: Tuberculosis Diagnostics (Latent TB) Market: Sales Value (in Million US$), 2016 & 2021
Figure 9: Global: Tuberculosis Diagnostics (Latent TB) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 10: Global: Tuberculosis Diagnostics (Active TB) Market: Sales Value (in Million US$), 2016 & 2021
Figure 11: Global: Tuberculosis Diagnostics (Active TB) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 12: Global: Tuberculosis Diagnostics (Radiographic Test) Market: Sales Value (in Million US$), 2016 & 2021
Figure 13: Global: Tuberculosis Diagnostics (Radiographic Test) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 14: Global: Tuberculosis Diagnostics (Laboratory Test) Market: Sales Value (in Million US$), 2016 & 2021
Figure 15: Global: Tuberculosis Diagnostics (Laboratory Test) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 16: Global: Tuberculosis Diagnostics (Nucleic Acid Testing) Market: Sales Value (in Million US$), 2016 & 2021
Figure 17: Global: Tuberculosis Diagnostics (Nucleic Acid Testing) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 18: Global: Tuberculosis Diagnostics (Cytokine Detection Test) Market: Sales Value (in Million US$), 2016 & 2021
Figure 19: Global: Tuberculosis Diagnostics (Cytokine Detection Test) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 20: Global: Tuberculosis Diagnostics (Drug Resistance Test) Market: Sales Value (in Million US$), 2016 & 2021
Figure 21: Global: Tuberculosis Diagnostics (Drug Resistance Test) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 22: Global: Tuberculosis Diagnostics (Others) Market: Sales Value (in Million US$), 2016 & 2021
Figure 23: Global: Tuberculosis Diagnostics (Others) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 24: Global: Tuberculosis Diagnostics (Hospitals and Clinics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 25: Global: Tuberculosis Diagnostics (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 26: Global: Tuberculosis Diagnostics (Diagnostics and Research Laboratories) Market: Sales Value (in Million US$), 2016 & 2021
Figure 27: Global: Tuberculosis Diagnostics (Diagnostics and Research Laboratories) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 28: Global: Tuberculosis Diagnostics (Other End-Users) Market: Sales Value (in Million US$), 2016 & 2021
Figure 29: Global: Tuberculosis Diagnostics (Other End-Users) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 30: North America: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 31: North America: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 32: United States: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 33: United States: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 34: Canada: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 35: Canada: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 36: Asia Pacific: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 37: Asia Pacific: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 38: China: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 39: China: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 40: Japan: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 41: Japan: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 42: India: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 43: India: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 44: South Korea: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 45: South Korea: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 46: Australia: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 47: Australia: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 48: Indonesia: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 49: Indonesia: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 50: Others: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 51: Others: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 52: Europe: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 53: Europe: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 54: Germany: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 55: Germany: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 56: France: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 57: France: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 58: United Kingdom: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 59: United Kingdom: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 60: Italy: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 61: Italy: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 62: Spain: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 63: Spain: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 64: Russia: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 65: Russia: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 66: Others: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 67: Others: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 68: Latin America: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 69: Latin America: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 70: Brazil: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 71: Brazil: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 72: Mexico: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 73: Mexico: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 74: Others: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 75: Others: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 76: Middle East and Africa: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 77: Middle East and Africa: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 78: Global: Tuberculosis Diagnostics Industry: SWOT Analysis
Figure 79: Global: Tuberculosis Diagnostics Industry: Value Chain Analysis
Figure 80: Global: Tuberculosis Diagnostics Industry: Porter’s Five Forces Analysis